Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain

Philippe Busque, Robert Higgins, François Caya, Sylvain Quessy

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Sreptococcus suis capsular type 2 is still an important cause of economic losses in the swine industry. At the present time, vaccination of pigs against this infection is generally carried out with autogenous bacterins and results are equivocal. In this study, the protective effect of a live avirulent S. suis type 2 strain (1330) which had induced a good protection in mice, was evaluated in swine. The experiment was performed in triplicate using 4 week-old piglets. A total of 15 piglets were vaccinated 3 times, 15 others were vaccinated 2 times, and 15 piglets were injected 3 times with sterile Todd-Hewitt broth. Using an indirect ELISA, an increase in the IgG response to S. suis antigens was noted in 27 of the 30 vaccinated piglets. On day 21 post-vaccination, all animals were challenged intravenously with a virulent S. suis type 2 strain (999). In the 2 vaccinated groups, 26 animals were fully protected. Only 1 out of the 15 piglets vaccinated 3 times developed mild clinical signs. In the group vaccinated twice, 3 piglets showed clinical signs and 1 of them died after the challenge. In the control group, 7 animals died out of the 11 with clinical signs of infection. In conclusion, a protective immunity was observed in swine when using strain 1330. However, more studies are needed to assess the use of a live S. suis strain in a vaccine for pigs.

Original languageEnglish (US)
Pages (from-to)275-279
Number of pages5
JournalCanadian Journal of Veterinary Research
Volume61
Issue number4
StatePublished - Dec 2 1997
Externally publishedYes

Fingerprint

Streptococcus suis
avirulent strains
piglets
Immunization
immunization
serotypes
Swine
swine
Infection
infection
Vaccination
Bacterial Vaccines
pork industry
vaccination
animals
Immunity
Industry
Vaccines
Immunoglobulin G
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain. / Busque, Philippe; Higgins, Robert; Caya, François; Quessy, Sylvain.

In: Canadian Journal of Veterinary Research, Vol. 61, No. 4, 02.12.1997, p. 275-279.

Research output: Contribution to journalArticle

@article{f4b5d2faf0d44b0ea401a6a64bbcd353,
title = "Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain",
abstract = "Sreptococcus suis capsular type 2 is still an important cause of economic losses in the swine industry. At the present time, vaccination of pigs against this infection is generally carried out with autogenous bacterins and results are equivocal. In this study, the protective effect of a live avirulent S. suis type 2 strain (1330) which had induced a good protection in mice, was evaluated in swine. The experiment was performed in triplicate using 4 week-old piglets. A total of 15 piglets were vaccinated 3 times, 15 others were vaccinated 2 times, and 15 piglets were injected 3 times with sterile Todd-Hewitt broth. Using an indirect ELISA, an increase in the IgG response to S. suis antigens was noted in 27 of the 30 vaccinated piglets. On day 21 post-vaccination, all animals were challenged intravenously with a virulent S. suis type 2 strain (999). In the 2 vaccinated groups, 26 animals were fully protected. Only 1 out of the 15 piglets vaccinated 3 times developed mild clinical signs. In the group vaccinated twice, 3 piglets showed clinical signs and 1 of them died after the challenge. In the control group, 7 animals died out of the 11 with clinical signs of infection. In conclusion, a protective immunity was observed in swine when using strain 1330. However, more studies are needed to assess the use of a live S. suis strain in a vaccine for pigs.",
author = "Philippe Busque and Robert Higgins and Fran{\cc}ois Caya and Sylvain Quessy",
year = "1997",
month = "12",
day = "2",
language = "English (US)",
volume = "61",
pages = "275--279",
journal = "Canadian Journal of Veterinary Research",
issn = "0830-9000",
publisher = "Canadian Veterinary Medical Association",
number = "4",

}

TY - JOUR

T1 - Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain

AU - Busque, Philippe

AU - Higgins, Robert

AU - Caya, François

AU - Quessy, Sylvain

PY - 1997/12/2

Y1 - 1997/12/2

N2 - Sreptococcus suis capsular type 2 is still an important cause of economic losses in the swine industry. At the present time, vaccination of pigs against this infection is generally carried out with autogenous bacterins and results are equivocal. In this study, the protective effect of a live avirulent S. suis type 2 strain (1330) which had induced a good protection in mice, was evaluated in swine. The experiment was performed in triplicate using 4 week-old piglets. A total of 15 piglets were vaccinated 3 times, 15 others were vaccinated 2 times, and 15 piglets were injected 3 times with sterile Todd-Hewitt broth. Using an indirect ELISA, an increase in the IgG response to S. suis antigens was noted in 27 of the 30 vaccinated piglets. On day 21 post-vaccination, all animals were challenged intravenously with a virulent S. suis type 2 strain (999). In the 2 vaccinated groups, 26 animals were fully protected. Only 1 out of the 15 piglets vaccinated 3 times developed mild clinical signs. In the group vaccinated twice, 3 piglets showed clinical signs and 1 of them died after the challenge. In the control group, 7 animals died out of the 11 with clinical signs of infection. In conclusion, a protective immunity was observed in swine when using strain 1330. However, more studies are needed to assess the use of a live S. suis strain in a vaccine for pigs.

AB - Sreptococcus suis capsular type 2 is still an important cause of economic losses in the swine industry. At the present time, vaccination of pigs against this infection is generally carried out with autogenous bacterins and results are equivocal. In this study, the protective effect of a live avirulent S. suis type 2 strain (1330) which had induced a good protection in mice, was evaluated in swine. The experiment was performed in triplicate using 4 week-old piglets. A total of 15 piglets were vaccinated 3 times, 15 others were vaccinated 2 times, and 15 piglets were injected 3 times with sterile Todd-Hewitt broth. Using an indirect ELISA, an increase in the IgG response to S. suis antigens was noted in 27 of the 30 vaccinated piglets. On day 21 post-vaccination, all animals were challenged intravenously with a virulent S. suis type 2 strain (999). In the 2 vaccinated groups, 26 animals were fully protected. Only 1 out of the 15 piglets vaccinated 3 times developed mild clinical signs. In the group vaccinated twice, 3 piglets showed clinical signs and 1 of them died after the challenge. In the control group, 7 animals died out of the 11 with clinical signs of infection. In conclusion, a protective immunity was observed in swine when using strain 1330. However, more studies are needed to assess the use of a live S. suis strain in a vaccine for pigs.

UR - http://www.scopus.com/inward/record.url?scp=0030683509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030683509&partnerID=8YFLogxK

M3 - Article

C2 - 9342451

AN - SCOPUS:0030683509

VL - 61

SP - 275

EP - 279

JO - Canadian Journal of Veterinary Research

JF - Canadian Journal of Veterinary Research

SN - 0830-9000

IS - 4

ER -